Home › Skin Cancer › NCT03775031
Chemical Peels and Fractional Laser on IGF-1 Levels in Skin
RecruitingHealthy volunteers welcome
Impact of Chemical Peels and Fractional Laser on IGF-1 Levels in Skin
Who can join
Ages 55 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Male and female subjects \>55 years old * Fitzpatrick type I-II * Able to provide informed consent. * Cutaneous photodamage of 3 or above on the Larnier photodamage scale (see Appendix). Exclusion Criteria: * Prior laser or peel treatment in the area evaluated in the current study in the past year. * Currently taking immunosuppressant medications known to interfere wound healing or anti-inflammatory medications (such as NSAIDs, or steroids). * Subjects who have underlying diseases that could alter wound healing response (such as Diabetes). * Currently taking insulin. * History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study. * History of abnormal scarring such as Keloids. * History of vitiligo. * Allergy or sensitivity or allergy to topical anesthesia * Inability to use sunscreen. * History of smoking in the last 10 years * Scar or prior surgery in the area of treatment. * Use of isotretinoin in the prior 6 months * Subjects who have bleeding disorders or who are taking anticoagulants
About the study
The purpose of this study is to evaluate the impact of fractional laser versus chemical peels on IGF-1 levels in skin.
What is being tested
- Fractional Laser and Chemical Peel (device)
Sponsor: Massachusetts General Hospital · Participants: 20 · Started: Dec 1, 2019
Contact the study team
- Molly Wanner, MD · Phone: 617-726-5066
Official record on ClinicalTrials.gov — NCT03775031
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital Clinical Unit for Research Trials and Outcomes in Skin, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.